A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons
about
Alternatives to currently used antimalarial drugs: in search of a magic bulletIdiosyncratic quinoline central nervous system toxicity: Historical insights into the chronic neurological sequelae of mefloquine.Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patientsThe global pipeline of new medicines for the control and elimination of malariaCreative solutions to extraordinary challenges in clinical trials: methodology of a phase III trial of azithromycin and chloroquine fixed-dose combination in pregnant women in Africa.Adverse neuropsychiatric effects of antimalarial drugs.Case Study of Small Molecules As Antimalarials: 2-Amino-1-phenylethanol (APE) Derivatives.A high performance liquid chromatographic assay of mefloquine in saliva after a single oral dose in healthy adult Africans.Mefloquine for preventing malaria during travel to endemic areas.Parasite physiology: No longer lost in translation.Development of medicines for the control and elimination of malaria
P2860
Q28070398-494C80F6-E54E-4993-981B-8895FDFA1C13Q33892018-1F6144B6-F35F-41B8-9191-5137C021E339Q35205935-3E6F6243-0583-4CBA-9C48-E914F884564EQ36278433-3C851757-6940-4672-8CB1-FBECBF75A995Q36320249-B428207A-6947-4D6C-815C-E168FC93F1C6Q36794459-9E953ABA-75D1-4B2A-96EA-7C154836FA52Q38808162-E5A79804-41A7-4D31-97D5-13AF920F23A3Q40809150-43BB50CB-25E5-49A1-BF02-E40CFA49BF28Q41839958-A7CCDF75-7D80-49DD-ADA1-E29079B1CC3CQ47140318-BAB33D0C-24D1-4678-A1A5-61229DEBE7EAQ47995158-BB2BF396-C89F-43C5-873D-7E39616898FDQ57019124-826A4278-A9FA-4786-9809-CD656E46C33E
P2860
A randomized, double-blind, placebo-controlled study to investigate the safety, tolerability, and pharmacokinetics of single enantiomer (+)-mefloquine compared with racemic mefloquine in healthy persons
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A randomized, double-blind, pl ...... mefloquine in healthy persons
@ast
A randomized, double-blind, pl ...... mefloquine in healthy persons
@en
A randomized, double-blind, pl ...... mefloquine in healthy persons
@nl
type
label
A randomized, double-blind, pl ...... mefloquine in healthy persons
@ast
A randomized, double-blind, pl ...... mefloquine in healthy persons
@en
A randomized, double-blind, pl ...... mefloquine in healthy persons
@nl
prefLabel
A randomized, double-blind, pl ...... mefloquine in healthy persons
@ast
A randomized, double-blind, pl ...... mefloquine in healthy persons
@en
A randomized, double-blind, pl ...... mefloquine in healthy persons
@nl
P2093
P2860
P1476
A randomized, double-blind, pl ...... mefloquine in healthy persons
@en
P2093
Anthony Priestley
Fiona Bull
Julie Lotharius
Jörg Möhrle
Robert Tansley
Stephan Duparc
P2860
P304
P356
10.4269/AJTMH.2010.10-0228
P407
P577
2010-12-01T00:00:00Z